Peer Review History
| Original SubmissionFebruary 7, 2023 |
|---|
|
PONE-D-23-02896New considerations for inclusion in research: Recruitment of pregnant and postpartum people who have experienced incarceration with substance use disordersPLOS ONE Dear Dr. Reddy, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 13 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Alan Farrier, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: This work was primarily supported by the UNC WRHR Career Development Program (K12 HD103085, PI Neal-Perry). However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: AK was funded by Grant # K12 HD103085, University of North Carolina Women's Reproductive Health Research Career Development Program, PI Neal-Perry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to review this manuscript, which presents qualitative data from 12 interviews with pregnant/postpartum people with opioid use disorder. The paper has many strengths, but could be improved in the following ways: -Please include additional information in the Introduction about the unique ethical considerations of conducting research with incarcerated populations and those in substance use treatment programs. The authors begin to discuss the systematic underrepresentation in research (p. 3), but the background on research in prisons, in particular, is warranted given the focus of the paper. -Pg. 5, Line 122 - define "recent past" -In the methods (p. 5), the authors mention that there were several differences between the pregnant/postpartum people who were incarcerated and those in treatment (e.g., compensation, having a prison staff member present). The authors should revisit this in the discussion. What are the potential limitations that follow from having these different (even if necessary) approaches and what are the implications of these limitations for their findings? Some commentary on the inherent ethical issues here seems important, too (e.g., the inequity inherent in being able to pay some participants in this study, but not others despite their equal participation). The authors may find a place for this on page 15 after line 373 or around lines 377-380. Alternatively, this could fit well in an expanded discussion of the issues raised on page 16 (lines 383-385). -More information is needed on the interview - What were some of the questions that were asked? How was the interview guide developed? Was the interview guided by prior work or a theoretical approach? What were the overall goals of the interview? Were the interview questions that were analyzed for this particular study part of a larger study. If so, please describe. To me, this is currently a major missing piece to this study and it's hard to interpret the results without more detail on the interview itself. For example, the authors note that many participants discussed the "value of longitudinal research" (p. 12) - were they asked specifically about this? or about their willingness to be interviewed in the future? It's just not clear what the results mean without knowing what participants were asked. -Pg. 6, Line 158 - I think there is a typo in this sentence which makes it unclear; please revise. -Please check the journal's guidelines for formatting direct quotes of different lengths; in many places I felt there was not enough interpretation/connection between quotes. -I found some of the quotes hard to follow or fit within one of the themes. For example, uncertainty about getting into a treatment program (p. 13) - where does this fit within the themes? -Were there any different themes by setting (prison vs. treatment)? It seems like one of the themes (financial benefit) isn't relevant for half of the sample. This should be acknowledged again the limitation of the sample. -Please clarify/expand what is meant by "Finally, the repeated ...in research studies." (pg. 15, Lines 364-366). -Please expand on the discussion of "protectionism" and provide relevant citations (pg. 17, line 408). Reviewer #2: Data is witheld in accordance with IRB approvals and this is acceptable. General I have to read this ‘from’ somewhere, and in my case it is the UK (as a feminist qualitative researcher and ethicist with an international hat). This is a really good paper. I realised quite how good it is, as after the first read through it followed me around for a few days (in the way a song will …), and I think there is something significant here. The core empirical findings and the participants voices are compelling. I am sure it will chime with many of us doing qualitative feminist research, but also in relation to research ethics. I hope the external eye is useful regarding polishing the clarity of the presentation, to maximise its usefulness. You will see from the notes below, there are some things missing from the general presentation which would help readers to understand – a few times I had the feeling I had skipped a section where something had been explained already, and went back to check … but I don’t think it was there. I have some concerns that the framing of ethics and governance issues is not clear enough between US-specific issues, general or wider issues, and thus the related generalisability of the implications for inclusion in research etc. I always give detailed reviews, so the word count below doesn’t reflect quality. Hopefully it will be clear what I think is needed, all of which is easily addressed, I think. I would strongly recommend publication with some minor revisions. Title / keywords These comments are for the authors to take from as they wish: I think the authors are underplaying the content slightly in the title and keywords. The lack of a keyword around the inclusion/perceptions of risk and benefit issues seems to be a gap – if I was looking for research like this (and I do) how would I find this article? The title is a problem for me – is there too much emphasis on the (researchers’) process of recruitment here? It doesn’t really represent the paper, as ironically one of the things I am asking for is more information about the recruitment process. I think ‘New considerations for inclusion in research’ is rather generic, and the paper isn’t about substance use in general. Can the authors find a way to say more clearly that it is a study into e.g., something closer to indicating - What the views of people with perinatal opioid use disorders (OUD) who have experienced incarceration can tell us about the benefits and risks of participation in qual research interviews to inform ethical inclusion ... Things I like I don’t need to say that it is well-written, but it is. I like the subtle contribution to the non-identification of participants of ‘approximately half’ in each group. I also like the seemingly effortless use of non-binary gendered language, which shows how easy it is do this. I like the quality of the participant data, which tells us a lot about the research team. And I like that the same code is identified as both a risk and a benefit (Helping Others. Making Change) I very much like the exploration of what we might call the ‘advocacy/change/impact misconception’ (akin to the ‘therapeutic misconception’ in clinical research.) This is really important, particularly as it is something researchers’ can affect (take responsibility for) in the way we present studies. Nature of the study These points need some clarification: It took me a while to work out that this paper was reporting the whole study – and that it was not an adjunct to a study ‘about’ something else, that had led to gathering research participants’ views on that experience. This is great, and quite innovative I think – we certainly need more robust research (as this is) about this area. But this needs to be a bit clearer (including in the abstract and title) – this is important not just for clarity but because it would highlight that this is a more unusual paper, especially in this criminal justice setting. There are various places where I thought, ‘But what did they tell the participants they were doing?; What questions did they ask in the interviews?’. Some of this is the inevitable ‘wanting to know more’ when you like something, but it is also about the presentation of the content so readers can orient ourselves to this study and its results. (See below). US setting of the study This needs some attention. This point is not related to generalisability of the results of the qualitative work, rather to the implications being drawn from them for wider ethics and governance frameworks. I think the authors have two options – either to present this study more clearly as a specifically local/national example, as research in the US via an IRB, with various limitations and implications for improving the situation in the US, which could then be discussed in an international context, or 2. to present the study as situated in the US, but having implications globally – I would prefer the latter, and assume that was your intention, but it currently sits too far in the middle. The most prominent issue for me is the specificity/limitations of the paper regarding ethics governance in the US. This needs to be addressed for accessibility and usefulness for an international audience, but is straightforward to do. For example the first sentence of the Introduction – does this whole sentence refer to the situation in the US, or is it only the final clause about incarcerated individuals in the US? I would like to see this setting/starting point more clearly framed from the very beginning. The Introduction could use a little tweaking to clarify which parts/claims are about the US specifically, and where/at what point it broadens to the wider / international situation. It invokes a lot of pertinent international literature, although I note not much that is very recent and the debate is moving fast (choice of action on that left to the authors). It would be helpful to clarify the specific/generic nature of the argument here, and at what point this shifts from one to the other. Simple signposting would do the trick. There is a strong dependence on the Belmont Report in framing the paper, which does not have the same function beyond the US (although it is a standard authoritative reference of course). This is more of a comment, which the authors can consider as they wish. I do want to ask if there are any guidelines in the US regarding research in this setting – statutory/professional/disciplinary etc? Is the Belmont Report the only point of reference for the guidelines mentioned (the rest seems to be academic literature, or possibly guidelines nested in that academic literature)? International comparisons This point is about the framing and presentation, which is the main thing that needs some development. The current recommendations/comments regarding governance have unacknowledged limitations, as there are different practices and expectations in other countries. Also different terminology regarding e.g., Research Ethics Committees as opposed to IRBs. Simply using a combination term (RECs/IRBs) would open this up. Some of the specific ethics/governance claims about IRB requirements would not apply in other countries, e.g., (381-83). I am not aware of any research situation internationally with a blanket ban on social media recruitment, in fact quite the opposite is true, especially since 2020. So this needs contextualising (was this perhaps study-specific?). And contra the situation described in the paper, in UK ethics review (and in many other countries and regarding international research codes), researchers are expected to consider the benefits and risks that potential research participants from all groups should be made aware of in order to give informed consent (90-93). This has led to the standard inclusion of ‘Patient and Public Involvement’, community consultation etc (or equivalent)s in research design, which is now a recommendation/requirement of many funders across the world. It is nowhere near perfect or adequate, but this situation doesn’t chime with the statements in the paper that there is no expectation on researchers to do this. Can the authors make it clear what they mean here? And would any references to the international literature (codes/guidelines) help? If you feel not, then don’t do it. Does the situation reported relate solely to the individual IRB approach for this study? Or is this more general in USA? This is of real interest to a wider readership, so even a couple of sentences would help to situate this. What was the informed consent process, and what were participants told? Informed consent processes are discussed several times, both generically, and specifically for this study. But I would like to be clearer about what material this contained and what the participants’ journeys were. The incarcerated participants received a flyer, but what did it say? How did they opt in following that? There is a subsequent process, but we don’t know what it is. In a context of incarceration discussing the autonomy of participants, this is crucial to understand. This connects to the data about participants’ decision-making processes, which would be stronger if we knew the context of what that process included for them. What does the consent form discussed in this study contain? In UK (again as an example but this is common practice elsewhere too) the standard process is that a consent form is a separate document which cross-refers to the Participant Information Sheet (usually constructed against a standard template), which includes all relevant details. So if someone only saw the consent form, they would not have much information. I think some simple more explanatory information here would be helpful for a wide international readership. The treatment programme participants had a different route into the study. Do we need to know anything more about this differentiation as it seems important? What did the presentations entail? Might it have impacted their understanding of the research? It sounds as though it was more interactive and discursive. Could any of this recruitment material go in as supplementary material (IRB approval allowing but there should be no reason why this couldn’t be shared)? That would make it easy to just add small points where relevant and cross-refer to the supplementary material. Results It would be good to know what the questions for the interview were – e.g., were the participants asked about other experiences of research (as suggested by some of the data)? A couple of sentences would be enough, with or without the schedule as supplementary material. It would be good to know what reasons participants were given to take part in the study/what the agenda was – and to know how that intersected with their decision-making and the data that emerged. For example on p11 (264-5) there is a reference to the research goal, but we don’t know what that was. Or how it was communicated to potential participants. 343-346 – This is just a comment from practice: I am curious about why there would not be an option for the participants to contact the researcher regarding future studies. It is standard practice in most settings for participants to be given the lead researcher’s (at least) contact details before they even opt-in, and although in practice people rarely use these, they are generally urged to keep the information for their records. So referring to this would be a straightforward way to keep lines of communication open (although the only time I tried it, no-one contacted us even though they said they would …). It may of course not be possible/feasible for incarcerated people to receive/keep this information, but those in e.g. a treatment programme might appreciate it? It would not resolve all the issues of course, but my point is that it is an existing mechanism which could help. No action is required here. Discussion Addressing a few points here would make it clearer – some are connected to those raised above. In my experience, especially in social-science/health type studies, much participant information refers to the benefit of sharing, helping others, improving services etc. Often in ethics review we have to roll this back a bit, to not over-promise to participants the realistic impact of their contributions. Again, is this context-specific? If there are such limitations where the authors are working this is of huge interest to others. I’m not sure what ‘ascertaining subjective perspectives of research participants during the study protocol’ means (359-60). Is something missing here? Knowing what participants were told (as above) would help consideration of their understanding of the boundary between research/advocacy as it would provide some context when we get to this central point. I’m confused about why there is a suggestion to extend ‘capacity’ to situational factors. Capacity is generally understood as literal clinical type capacity to understand, and there is quite rightly much discussion about e.g., not excluding people with dementia, or those with learning disabilities from research on this basis. I doubt it is intended, but currently this point sounds like it plays into the hands of paternal exclusionists, or ‘protectionism’ (385), which the authors say they want to resist, and I am not sure what purpose it serves here. Given the international debate about challenging concepts of vulnerability in research mentioned (388-90 which again seems maybe light on the standard/recent literature, but again is the authors’ decision to act or not) this seems out of step – do you need this here at all? Or if you do want to include it, can you clarify what you mean? As a tiny point (361) It would be helpful just to clarify if there was actually a risk of breach of confidentiality (which I doubt) or was it a perceived (highly justifiable) concern for participants? Julie Cook ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr Julie Cook ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-02896R1Ethical Inclusion: Risks and benefits of research from the perspective of perinatal people with opioid use disorders who have experienced incarcerationPLOS ONE Dear Dr. Reddy, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 24 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Alan Farrier, Ph.D Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Well done on the revisions to this paper! It has just come back from the second review with a few minor comments to address from one of the reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have done a great job incorporating feedback from the first review. The manuscript is significantly improved. I have a few minor comments: -The first paragraph of the manuscript reads as overly broad and I'm not sure that it is necessary to start the paper. If the authors choose to retain this paragraph, then there should probably be citations included for the first and second sentences in this paragraph -- if this is "common knowledge" then I'm not quite sure it's necessary to include any of this text to start the paper. -Please spell out United States and give the abbreviation and then use the abbreviation from that point forward consistently. -Check grammar/sentence structure of the first sentence under eligibility and consent (p. 5, line 131) -Two subheadings now refer to consent (pp. 5 & 6). I would remove 'consent' from p. 5 (line 130). -The sentence re: payment feels out of place (p. 6, line 158-160) because participants would be compensated after they consented. I would move this sentence to the last sentence before analysis (p. 8). -On Page 8, lines 190-191 -- I think you need to make it clear that the main objective of the interview questions that *were used in this study* were to inform robust recruitment and community retention processes. It's clear from the Appendix B that there were other questions included that were there for other purposes (and not presented in this paper). I would just try to make that clear that for *this* paper/study, you pulled out specific questions (Sections 2 & 4, specifically) from the broader interview protocol. -There are weird lines that appear throughout the paper and I'm not sure if they're intended to be there (e.g., p. 9, 14, 15). Reviewer #2: Just to say I have nothing else to add to a review. I really like this paper. I am glad to have been able to support it, and look forward to seeing it in print (and being able to cite it). I would also like to thank the authors for the positive responses to the review and engagement with it. The changes have made it better. Do you realise you have written an empirical ethics paper? That may be worth you exploring ... ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Julie Cook ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Ethical Inclusion: Risks and benefits of research from the perspective of perinatal people with opioid use disorders who have experienced incarceration PONE-D-23-02896R2 Dear Dr. Juila Reddy, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Alan Farrier, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-02896R2 Ethical Inclusion: Risks and benefits of research from the perspective of perinatal people with opioid use disorders who have experienced incarceration Dear Dr. Reddy: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Alan Farrier Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .